DBVT Q2 2021 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$7M

Operating Income

-$30M

Net Income

-$31M

EPS (Diluted)

$-2.80

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$201M

Total Liabilities

$58M

Stockholders' Equity

$143M

Cash & Equivalents

$125M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$4M	-100.0%
Gross Profit	-$7M	$4M	-297.4%
Operating Income	-$30M	-$48M	+37.9%
Net Income	-$31M	-$48M	+36.5%